EFEarnings Feed

T

Company dossier

TITAN PHARMACEUTICALS INC

Ticker TTNPCIK 0000910267SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

8 items

8-KAccepted Dec 2, 7:00 PM ETAcc 0001005477-99-005654
TITAN PHARMACEUTICALS INC7.6 KB
TITAN PHARMACEUTICALS INC 8-K
View filing
10-QAccepted Nov 14, 7:00 PM ETAcc 0000912057-99-006049
TITAN PHARMACEUTICALS INC150.5 KB
TITAN PHARMACEUTICALS INC 10-Q
View filing
8-KAccepted Oct 18, 8:00 PM ETAcc 0001005477-99-004795
TITAN PHARMACEUTICALS INC12.5 KB
TITAN PHARMACEUTICALS INC 8-K
View filing
10-QAccepted Aug 15, 8:00 PM ETAcc 0001047469-99-032359
TITAN PHARMACEUTICALS INC39.6 KB
TITAN PHARMACEUTICALS INC 10-Q
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0001047469-99-021002
TITAN PHARMACEUTICALS INC42.8 KB
TITAN PHARMACEUTICALS INC 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0001047469-99-012888
TITAN PHARMACEUTICALS INC246.8 KB
TITAN PHARMACEUTICALS INC 10-K
View filing
8-KAccepted Jan 27, 7:00 PM ETAcc 0001005477-99-000185
TITAN PHARMACEUTICALS INC8.0 KB
TITAN PHARMACEUTICALS INC 8-K
View filing
10-QAccepted Nov 15, 7:00 PM ETAcc 0001047469-98-040928
TITAN PHARMACEUTICALS INC47.2 KB
TITAN PHARMACEUTICALS INC 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 1

Ticker roster

TTNP
Nasdaq
Exchange hub ↗

Addresses

business
400 OYSTER POINT BLVD SUITE 505
SAN FRANCISCO, CA, 94080
mailing
400 OYSTER POINT BLVD SUITE 505
SAN FRANCISCO, CA, 94080